Lapi Group at University of Alabama at Birmingham

Recent publications (last 2 years from a total of 65)


1.    Wooten, A.L. Lewis, B.C., Lapi, S.E. (2015) Cross-sections of (p,x) reactions on natural chromium for the production of 52,52m,54Mn radioisotopes Applied Radiation and Isotopes 96; 154-161


2.    Richards V.N., Rath N., Lapi S.E. (2015) Production and separation of 186gRe from proton bombardment of 186WC. Nuclear Medicine and Biology 6:530-5


3.    Aweda, T., Zhang, S., Mupanomunda, C., Burkemper, J., Seong Heo, G. Bandara, N., Lin, M., Cutler, C.S., Cannon, C.L., Youngs, W.J., Lapi, S.E. (2015) Investigating the pharmacokinetics and biological distribution of silver-loaded polyphosphoester-based nanoparticles using 111Ag as a radiotracer Journal of Labelled Compounds and Radiopharmaceuticals 58(6):234-41


4.    Zheleznyak, A., Garbow, J.R., Neeman, M., Lapi, S.E. (2015) Preclinical PET imaging of acute hyperoxia therapy of chronic hypoxia during pregnancy Molecular Imaging 14:366-72.


5.    Mastren, T., Marquez, B.V., Sultan, D., Bollinger, E., Eisenbeis, P., Voller, T., Lapi, S.E. (2015) Cyclotron production of high specific activity 55Co and in vivo evaluation of the stability of 55Co metal-chelate-peptide complexes Molecular Imaging 14:11-22


6.    Mastren, T., Pen, A., Loveless, S., Marquez, B., Bolliger, E., Marois, B., Hubley, N., Broan, K., Morrissey, D., Peaslee, G., Lapi, S.E. (2015) Harvesting 67Cu from the Collection of a Secondary Beam Cocktail at the National Superconducting Cyclotron Laboratory Analytical Chemistry 87(20)10323-9


7.    Burkemper, J.L., Huang, C., Li, A., Yuan, Rich, K., McConathy, J., Lapi, S.E. (2015) Synthesis and Biological Evaluation of (S)-amino-2-methyl-4-[76Br]-bromo-3-(E)-butenoic Acid (BrVAIB) for Brain Tumor Imaging Journal of Medicinal Chemistry 58(21)8542-52


8.    Bandara, N., Cherkuri, K., Zheleznyak, A., Griffith, D.A., Limberakis, C., Tess, D.A., Chen, J., Waterhouse, R., Lapi, S.E. (2016) Evaluation of 64Cu and 68Ga Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β-cell Imaging Molecular Imaging and Biology 18(1) 90-8


9.    Wright, B.D., Whittenberg, J., Desai, A., DiFelice, C., Kenis, P.J.A, Lapi, S.E., Reichert, D. (2016) Microfluidic Preparation of an 89Zr-Labeled Trastuzumab Single Patient  Dose Journal of Nuclear Medicine 57 (5) 747-52


10.  Lange, S.E.S., Zheleznyak A., Studer, M.,, O’Shannessy D.J., Lapi S.E., Van Tine B.A. (2016) Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET Applications Oncotarget 7 (11) 13082-92


11.  Nie, X., Randolph, G.J., Elvington, A., Bandara, N., Zheleznyak, A. Gropler, R.J., Woodard, P.K., Lapi, S.E. Imaging of hypoxia in mouse atherosclerotic plaques with 64Cu-ATSM Nuclear Medicine and Biology, 43(9)534-542


12.  Wooten AL, Lewis BC, Szatkowski DJ, Sultan DH, Abdin KI, Voller TF, Liu Y, Lapi S.E. Calibration setting numbers for dose calibrators for the PET isotopes 52Mn, 64Cu, 76Br, 86Y, 89Zr, 124I. Appl Radiat Isot 113:89-95.


13.  Gordon L, Lapi SE, Anderson C, Schwarz SW; SNMMI Committee on Women in Nuclear Medicine. Working Together to Advance Women in Nuclear Medicine. J Nucl Med. 2016 Sep;57(9):14N


14.  Graaf MD, Marquez BV, Yeh NH, Lapi SE, Moeller KD. New Methods for the Site-Selective Placement of Peptides on a Microelectrode Array: Probing VEGF-v107 Binding as Proof of Concept. ACS Chem Biol. 2016 Sep 1.


15.  Nie X, Randolph GJ, Elvington A, Bandara N, Zheleznyak A, Gropler RJ, Woodard PK, Lapi SE. Imaging of Hypoxia in Mouse Atherosclerotic Plaques with (64)Cu-ATSM. Nucl Med Biol. 2016 Sep;43(9):534-42.


16.  Jin, H., Yang, H., Zhang, Y.,Zhange, X., Rosenberg, A.J., Liu, Y., Lapi, S.E., Tu, Z. (2016) A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury. J Nucl Cardiol. 2016 Feb 2.  


17.  Laforest, R., Lapi, S.E., Oyama, R., Bose, R.,Tabchy, A., Marquez-Nostra, B.V., Burkemper, J., Wright, B.D., Frye, J., Frye, S. Siegel, B.A., Dehdashti, F. (2016) [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer. Mol Imaging and Biology. 2016 May 4.